Please login to the form below

Not currently logged in
Email:
Password:

Switched Oncology

This page shows the latest Switched Oncology news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • Cancer in The Information Age: are we illuminated or inundated? Cancer in The Information Age: are we illuminated or inundated?

    But with change comes both challenges and opportunities. Havas Lynx’s SWITCHED ONcology initiative invited healthcare leaders to share their perspectives on the challenges facing oncology, and discuss what this means ... Ben Pounds is a medical writer

  • Beyond caring: learning from the unsung advocates in cancer care

    Watch the full Switched Oncology Caregivers Experience focus group here or visit Switched Oncology for more information. ... Steffi Evans is a medical writer and executive faculty member of Switched Oncology.

  • Let’s change the conversation about cancer Let’s change the conversation about cancer

    This changing conversation was explored at a recent focus group organised by Havas Lynx as part of their Switched Oncology initiative. ... Watch the full Switched Oncology Patient Experience focus group here or visit Switched Oncology for more information

  • Intellectual property threats in the BRIC markets Intellectual property threats in the BRIC markets

    IP risk has since switched to innovative oncology products. India has been by far the most active country in targeting IP protection to increase access to innovative oncology products. ... This article is based on the May 2013 IMSCG White Paper Securing

More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics